Antibody against BP 230 and BP 180 seen in
**Core Concept**
The question is testing knowledge of autoimmune bullous diseases, specifically the targets of autoantibodies in these conditions. **Bullous pemphigoid** is a chronic autoimmune skin disease characterized by the presence of autoantibodies against specific proteins in the skin.
**Why the Correct Answer is Right**
Autoantibodies against **BP 230** and **BP 180** are characteristic of bullous pemphigoid. These proteins are components of the hemidesmosomes, which are critical for the adhesion of the epidermis to the dermis. The autoantibodies disrupt this adhesion, leading to blister formation.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not specified, but typically, other conditions like pemphigus vulgaris involve different autoantibody targets.
**Option B:** Incorrect as it is not provided, but generally, conditions like epidermolysis bullosa acquisita involve autoantibodies against type VII collagen, not BP 230 and BP 180.
**Option C:** Incorrect because, similar to Option B, it would likely involve a different set of autoantibodies.
**Option D:** Incorrect for the same reasons as Options B and C.
**Clinical Pearl / High-Yield Fact**
Bullous pemphigoid is a significant condition to recognize due to its potential for severe blistering and the importance of distinguishing it from other bullous diseases, both for treatment and prognosis.
**Correct Answer:** D. Bullous Pemphigoid.